Spectrum Volume 17 Issue 10 - October 27, 1994
Spectrum would like to clarify an aspect of an article concerning brucellosis research under way in the VMRCVM which appeared in the Oct. 20, 1994, edition.
Faculty members in the college are concerned that a sentence describing one goal of the research could be misinterpreted in a way that suggests the United States Army is engaged in the process of developing biological-warfare weapons.
One reason the VMRCVM researchers are attempting to develop a human vaccine for brucellosis is to protect American troops from adversaries that might use brucellosis as a biological warfare weapon against them.
Finally, one of the researchers associated with the project was improperly identified in the article as Nathan Sriranganathan. Sriranganathan's first name is Nammalwar.
We regret any confusion or inconvenience this may have caused our readers.